These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20564348)

  • 1. Members of the low-density lipoprotein receptor-related proteins provide a differential molecular signature between parental and CD133+ DAOY medulloblastoma cells.
    Annabi B; Doumit J; Plouffe K; Laflamme C; Lord-Dufour S; Béliveau R
    Mol Carcinog; 2010 Jul; 49(7):710-7. PubMed ID: 20564348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
    Srivastava VK; Nalbantoglu J
    Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.
    Blazek ER; Foutch JL; Maki G
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):1-5. PubMed ID: 17084552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
    Annabi B; Rojas-Sutterlin S; Laflamme C; Lachambre MP; Rolland Y; Sartelet H; Béliveau R
    Mol Cancer Res; 2008 Jun; 6(6):907-16. PubMed ID: 18567795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells.
    Cox JL; Wilder PJ; Desler M; Rizzino A
    PLoS One; 2012; 7(8):e44087. PubMed ID: 22937156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors.
    Yi JM; Tsai HC; Glöckner SC; Lin S; Ohm JE; Easwaran H; James CD; Costello JF; Riggins G; Eberhart CG; Laterra J; Vescovi AL; Ahuja N; Herman JG; Schuebel KE; Baylin SB
    Cancer Res; 2008 Oct; 68(19):8094-103. PubMed ID: 18829568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative gene-expression profiling of CD133(+) and CD133(-) D10 melanoma cells.
    Roudi R; Ebrahimi M; Sabet MN; Najafi A; Nourani MR; Fomeshi MR; Samadikuchaksaraei A; Shariftabrizi A; Madjd Z
    Future Oncol; 2015; 11(17):2383-93. PubMed ID: 26285774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic Stem Cell-Related Protein L1TD1 Is Required for Cell Viability, Neurosphere Formation, and Chemoresistance in Medulloblastoma.
    Santos MC; Silva PB; Rodini CO; Furukawa G; Marco Antonio DS; Zanotto-Filho A; Moreira JC; Okamoto OK
    Stem Cells Dev; 2015 Nov; 24(22):2700-8. PubMed ID: 26159230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases.
    Boivin D; Labbé D; Fontaine N; Lamy S; Beaulieu E; Gingras D; Béliveau R
    Biochemistry; 2009 May; 48(18):3998-4007. PubMed ID: 19296573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein.
    Osmond TL; Broadley KW; McConnell MJ
    Int J Mol Med; 2010 Jun; 25(6):883-8. PubMed ID: 20428792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
    Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133 is a marker of bioenergetic stress in human glioma.
    Griguer CE; Oliva CR; Gobin E; Marcorelles P; Benos DJ; Lancaster JR; Gillespie GY
    PLoS One; 2008; 3(11):e3655. PubMed ID: 18985161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma.
    Nakai E; Park K; Yawata T; Chihara T; Kumazawa A; Nakabayashi H; Shimizu K
    Cancer Invest; 2009 Nov; 27(9):901-8. PubMed ID: 19832037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypomethylation regulates CD133 expression in human gliomas.
    Tabu K; Sasai K; Kimura T; Wang L; Aoyanagi E; Kohsaka S; Tanino M; Nishihara H; Tanaka S
    Cell Res; 2008 Oct; 18(10):1037-46. PubMed ID: 18679414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation.
    He H; Nilsson CL; Emmett MR; Marshall AG; Kroes RA; Moskal JR; Ji Y; Colman H; Priebe W; Lang FF; Conrad CA
    J Proteome Res; 2010 May; 9(5):2098-108. PubMed ID: 20199106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulation of AC133 and CD133 in glioblastoma.
    Campos B; Zeng L; Daotrong PH; Eckstein V; Unterberg A; Mairbäurl H; Herold-Mende C
    Glia; 2011 Dec; 59(12):1974-86. PubMed ID: 21901757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations.
    Yan X; Ma L; Yi D; Yoon JG; Diercks A; Foltz G; Price ND; Hood LE; Tian Q
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1591-6. PubMed ID: 21220328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CD133 antigen in cancer.
    Ferrandina G; Petrillo M; Bonanno G; Scambia G
    Expert Opin Ther Targets; 2009 Jul; 13(7):823-37. PubMed ID: 19530986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.